1Noordzij M, Cranenburg EM, Engelsman LF, et al. Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients[J]. Nephrol Dial Transplant, 2011, 26(5): 1662-1669. DOI: 10. 1093/ndt/gfq582. 被引量：1
2Karohl C, D'Marco Gasc6n L, Raggi P. Noninvasive imaging for assessment of calcification in chronic kidney disease[J]. Nat Rev Nephrol, 2011, 7(10): 567- 577. DOI: 10.1038/nmeph. 2011.110. 被引量：1
3Chen NX, Moe SM. Vascular calcification: pathophysiology and risk factors[J]. Curr Hypertens Rep, 2012, 14(3): 228-237. DOI: 10.1007/s11906-012-0265-8. 被引量：1
4Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography [J]. J Am Coil Cardiol, 1990, 15(4): 827-832. 被引量：1
5Bashir A, Moody WE, Edwards NC, et al. Coronary artery calcium assessment in CKD: utility in cardiovascular disease risk assessment and treatment?[J]. Am J Kidney Dis, 2015, 65 (6): 937-948. DOI: 10.1053/j.ajkd.2015.01.012. 被引量：1
6Shimoyama Y, Tsuruta Y, Niwa T. Coronary artery calcification score is associated with mortality in Japanese hemodialysis patients[J]. J Ren Nutr, 2012, 22(1): 139-142. DOI: 10.1053/j. jrn.2011.10.024. 被引量：1
7Gonqalves FL, Elias RM, dos Reis LM, et al. Serum sclerostin is an independent predictor of mortality in hemodialysis patients[J]. BMC Nephrol, 2014, 15:190-196. DOI: 10.1186/ 1471-2369-15-190. 被引量：1
8Drechsler C, Evenepoel P, Vervloet MG, et al. High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study[J]. Nephrol Dial Transplant, 2015, 30(2): 288 -293. DOI: 10.1093/ndt/gfu301. 被引量：1
9Silverman SL. Sclerostin[J]. J Osteoporos, 2010, 2010:941419. DOI: 10.4061/2010/941419. 被引量：1
10Zhu D, Mackenzie NC, Millan JL, et al. The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells[J]. PLoS One, 2011, 6(5): e19595. DOI: 10.1371/journal.pone.0019595. 被引量：1
